Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 169

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 169
---
 Prior thereto, he was from January 2013 to February 2017 he was Chief Financial
Officer at Secure Islands Technologies, a cybersecurity firm acquired by Microsoft, where he led financial operations across the US,
UK, and Switzerland, managed investor relations, and was instrumental in both a $20 million fundraising round and the Microsoft acquisition
process. From February 2008 to January 2013, he was Chief Financial Officer at Van Leer Technology Ventures, a venture company, where
he oversaw all financial reporting. Prior thereto from 2004 to 2008, he was associated with the Israel office of Deloitte, where he led
and participated in numerous financial audits for organization of various sizes.

Mr. Avraham is a licensed CPA and holds an MBA
in Finance from the Hebrew University of Jerusalem.

Inna Martin, 49, has joined the Company
as Chief Executive Officer, President and director in November 2019 and served as Chief Executive Officer through December 22, 2024, whereupon
she resigned from such position, but continues to serve as a director and President of the Company. Since December 17, 2024, she is serving
as Chief Operating Officer. Ms. Martin has an extensive experience of more than 20 years in healthcare and project management.Between December 2022 and February 2024, she served on the board of directors of IR Med, Inc. (OTCQB: IRME),
a clinical stage medical device company focused on the development of infrared spectroscopy and AI analysis technology platform as a basis
for point-of-care decision support devices. From February 2014 until April 2018, Inna Martin served as Investment Director at a Luxembourg
based, a healthcare focused VC fund, partner of Domain Associates LLC (USA), where she managed portfolio companies in major innovation
hubs including North America and Europe. In September 2018, she founded Seven Sons Ltd., Israel, a clinical stage medical device company,
focusing on the development of Stent Positioning Assistance System, SPAS, a novel proprietary tool developed for safer PCI procedure and
precise stent positioning.

Inna Martin received her MBA in 2000 fromBar Ilan University, Israel, her BA in English and Psychology in 1996 from Orenburg State University, Russian
Federation. In 2021, she received certification in Management Executive Education, Artificial Intelligence in Health Care from MIT, MA.

Arie Gordashnikov, 42,